Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 2,220 shares at $25.22 ($56K) on 2021-05-11, disclosed to the SEC on 2021-05-13.
Scheduled sale ($56k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.22 | 1,090 | $27K | 49.3% |
| 2 | $25.02 | 400 | $10K | 17.9% |
| 3 | $25.04 | 730 | $18K | 32.8% |
| Total | $25.12 avg | 2,220 | $56K | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |